| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113883.3.117.1.7.1.201 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.117.1.7.1.201/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.117.1.7.1.201 |
| Version | 20250206 |
| Status | active |
| Date | 2025-02-06T01:09:49-05:00 |
| Name | AntithromboticTherapyAnticoagulant |
| Title | Antithrombotic Therapy Anticoagulant |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts of medications that are anticoagulant medications used to reduce stroke mortality and morbidity.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication that is an antithrombotic medication, including oral, rectal, and injectable dose forms.),(Exclusion Criteria: Excludes concepts that represent enoxaparin and heparin generally given for VTE prophylaxis.) |
FHIR